Prevención y diagnóstico precoz de la sordera por ototóxicos

• Núñez Batalla, Faustino ^[2] ; Jáudenes Casaubón, Carmen ^[3] ; Sequí Canet, José Miguel ^[1] ; Vivanco Allende, Ana ^[1] ; Zubicaray Ugarteche, José ^[2]
  1. [1] Asociación Española de Pediatría

     Asociación Española de Pediatría

     Madrid, España

     
  2. [2] Sociedad Española de Otorrinolaringología
  3. [3] Confederación Española de Familias de Personas Sordas (FIAPAS)

  Mostrar afiliaciones +
• Localización: Revista Española de Discapacidad (REDIS), ISSN-e 2340-5104, Vol. 9, Nº. 2, 2021 (Ejemplar dedicado a: REVISTA ESPAÑOLA DE DISCAPACIDAD | Diciembre 2021 - Mayo 2022), págs. 155-178
• Idioma: español
• DOI: 10.5569/2340-5104.09.02.09
• Títulos paralelos:
  • Prevention and early diagnosis of ototoxic hearing loss
• Enlaces
  • Texto completo (pdf)
• Dialnet Métricas: 1 Cita
• Resumen

  • Núñez, F. (2021). Prevención y diagnóstico precoz de la sordera por ototóxicos: recomendaciones CODEPEH 2020. Revista Española de Discapacidad, 9(2), pp. 155-178.

• Referencias bibliográficas
  • Abujamra, A. L. et al. (2013). The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients...
  • Arslan, E. et al. (1999). Global problem of drug-induced hearing loss. Ann N Y Acad Sci, 884, pp. 1-14.
  • Astolfi, L. et al. (2016). Coenzyme Q10 plus multivitamin treatment prevents cisplatin ototoxicity in rats. PLoS One, 11(9), p. e0162106.
  • Bass, J. K. y Bhagat, S. P. (2014). Challenges in ototoxicity monitoring in the pediatric oncology population. J Am Acad Audiol, 25, pp. 760-774.
  • Bisht, M. y Bist, S. S. (2011). Ototoxicity: the hidden menace. Indian J Otolaryngol Head Neck Surg, 63, pp. 255-259.
  • Bitner-Glindzicz, M. et al. (2009). Prevalence of mitochondrial 1555A-->G mutation in European children. N Engl J Med, 360(6), pp. 640-642.
  • Brock, P. R. et al. (2012). Platinum-induced ototoxicity in children: A consensus review on mechanisms, predisposition, and protection, including...
  • Budai, B. et al. (2020). Géczi GSTM1 null and GSTT1 null: Predictors of cisplatin-caused acute ototoxicity measured by DPOAEs. J Mol Med (Berl),...
  • Cianfrone, G. et al. (2011). Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: A reasoned and updated guide. Eur...
  • Clemens, E. et al. (2019). Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: A report...
  • Clemens, E. et al. (2020). Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate...
  • Coradini, P. P. et al. (2007). Ototoxicity from cisplatin therapy in childhood cancer. J Pediatr Hematol Oncol, 29, pp. 355-360.
  • Crabb, S. J. et al. (2017). COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial...
  • Crundwell, G. et al. (2016). Ototoxicity (cochleotoxicity) classifications: A review. Int J Audiol, 55(2), pp. 65-74. Davis, B. D. (1987)....
  • Dogan, M. et al. (2017). Protective role of misoprostol in prevention of gentamicin ototoxicity. Int J Pediatr Otorhinolaryngol, 96, pp. 140-144.
  • Dogan, M. et al. (2018). Utilizing prestin as a predictive marker for the early detection of outer hair cell damage. Am J Otolaryngol, 39(5),...
  • Dos Santos, N. A. G. et al. (2020). Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol,...
  • Drögemöller, B. I. et al. (2018). Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced...
  • Dulon, D. et al. (1988). Relationship between the nephrotoxicity and ototoxicity induced by gentamicin in the Guinea pig. Acta Oto-Laryngologica,...
  • Dulon, D. et al. (2013). Ototoxicidad farmacológica. EMC-Otorrinolaringología, 42, pp. 1-13.
  • Duval, M. y Daniel, S-J. (2012). Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity. Journal of Otolaryngology-Head...
  • El-Anwar, M. W. et al. (2018). Protective effect of pentoxifylline on amikacin-induced ototoxicity. Ear NoseThroat J, 97(8), pp. E8-E12.
  • El-Barbary, M. N. et al. (2015). Gentamicin extended interval regimen and ototoxicity in neonates. Int J Pediatr Otorhinolaryngol, 79, pp....
  • Fligor, B. J. (2019). Pediatric ototoxicity: current trends and management. Seminars in Hearing, 40, pp. 154-161.
  • Forge, A. y Li, L. (2000). Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res, 139, pp. 97-115.
  • Fox, D. J. et al. (2016). D-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models. Journal...
  • Fransson, A. E. et al. (2017). Hydrogen inhalation protects against ototoxicity induced by intravenous cisplatin in the Guinea pig. Front...
  • Freyer, D. R. et al. (2017). Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children...
  • Ganesan, P. et al. (2018). Ototoxicity: A challenge in diagnosis and treatment. J Audiol Otol, 22, pp. 59-68.
  • Gallo-Terán, J. et al. (2002). Incidence of A1555G mutations in the mitochondrial DNA and 35delG in the GJB2 gene (connexin-26) in families...
  • Gu, J. et al. (2020). Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): Assessment of potential otoprotective effects. J Nanobiotechnology,...
  • Guo, J. et al. (2019a). Protection of hair cells from ototoxic drug-induced hearing loss. En H. Li y R. Chai (Eds.), Hearing loss: Mechanisms,...
  • Guo, S. et al. (2019b). Rapamycin protects spiral ganglion neurons from gentamicin-induced degeneration in vitro. J Assoc Res Otolaryngol,...
  • Hamstra, D. A. et al. (2010). Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without...
  • Hana, R. S. y Bawi B. L. (2018). Prestin, otolin-1 regulation, and human 8-oxoG DNA glycosylase 1 gene polymorphisms in noise-induced hearing...
  • Hirvonen, T. P. et al. (2005). Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla. J Neurophysiol,...
  • Holzer, A. K. et al. (2004). The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian...
  • Huang, S. et al. (2013). Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells...
  • Husain, K. et al. (2005). Partial protection by lipoic acid against carboplantin-induced ototoxicity in rats. Biomedical and Environmental...
  • Igumnova, V. et al. (2019). The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population:...
  • Ishikawa, M. et al. (2019). Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics...
  • Jing, W. et al. (2015). Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis....
  • Juhn, S. K. et al. (1981). Nature of blood-labyrinth barrier in experimental conditions. Ann Otol Rhinol Laryngol, 90, pp. 135-141.
  • Kil, J. E. et al. (2017). Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: A randomised, double-blind, placebo-controlled,...
  • King, K. A. y Brewer, C. C. (2018). Clinical trials, ototoxicity grading scales, and the audiologist´s role in therapeutic decision making....
  • Knight, K. R. et al. (2005). Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may...
  • Knight, K. R. et al. (2017). Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1):...
  • Kotecha, B. y Richardson, G. P. (1994). Ototoxicity in vitro: Effects of neomycin, gentamicin, dihydrostreptomycin, amikacin, spectinomycin,...
  • Kranzer, K. et al. (2015). A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced...
  • Kros, C. J. y Steyger, P. S. (2019). Aminoglycoside- and cisplatin-induced ototoxicity: Mechanisms and Otoprotective Strategies. Cold Spring...
  • Kucharava, K. et al. (2019). Pasireotide protects mammalian cochlear hair cells from gentamicin ototoxicity by activating the PI3K-Akt pathway....
  • Lanvers-Kaminsky, C. et al. (2017). Drug-induced ototoxicity: Mechanisms, pharmacogenetics and protective strategies. Clinical Pharmacology...
  • Lanvers-Kaminsky, C. y Ciarimboli, G. (2017). Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin. Pharmacogenomics,...
  • Laurell, G. (2019). Pharmacological intervention in the field of ototoxicity. HNO, 67(6), pp. 434-439.
  • Le Prell, C. G. (2019). Otoprotectants: From research to clinical application. Semin Hear, 40(2), pp. 162-176.
  • Lee, J. E. et al. (2004). Signaling pathway for apoptosis of vestibular hair cells of mice due to aminoglycosides. Acta Otolaryngol, 124,...
  • Lee, S. H. et al. (2018). Circulating serum miRNA-205 as a diagnostic biomarker for ototoxicity in mice treated with aminoglycoside antibiotics....
  • Lewis, M. et al. (2009). Ototoxicity in children treated for osteosarcoma. Pediatric Blood Cancer, 52, pp. 387-391.
  • Ma, W. et al. (2015). Ginkgolide B protects against cisplatin-induced ototoxicity: Enhancement of Akt–Nrf2–HO-1 signaling and reduction of...
  • Maru, D. y Malky, G. A. (2018). Current practice of ototoxicity management across the United Kingdom (UK). Int J Audiol, 57(sup4), pp. S76-S88.
  • More, S. S. et al. (2010). Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci, 30, pp. 9500-9509.
  • Mulry, E. y Parham, K. (2020). Inner ear proteins as potential biomarkers. Otol Neurotol, 41(2), pp. 145-152.
  • Nguyen, T. y Jeyakumar, A. (2019). Genetic susceptibility to aminoglycoside ototoxicity. Int J Pediatr Otorhinolaryngol, 120, pp. 15-19.
  • Núñez, F. et al. (2015). Recomendaciones CODEPEH 2014 (sorderas diferidas y sobrevenidas en la infancia). Revista Española de Discapacidad,...
  • Olivier, T. W. et al. (2019). Cognitive implications of ototoxicity in pediatric patients with embryonal brain tumors. J Clin Oncol, 37, pp....
  • O’Reilly, M. et al. (2019). Gentamicin affects the bioenergetics of isolated mitochondria and collapses the mitochondrial membrane potential...
  • Özel, H. E. et al. (2016). Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced...
  • Paciello, F. et al. (2020). The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatininduced ototoxicity....
  • Pham, T. N. M. et al. (2020). Protective mechanisms of avocado oil extract against ototoxicity. Nutrients, 12(4), p. 947.
  • Prayuenyong, P. et al. (2020). The efficacy of statins as otoprotective agents: A systematic review. Clin Otolaryngol, 45(1), pp. 21-31.
  • Ramaswamy, B. et al. (2017). Magnetic nanoparticle mediated steroid delivery mitigates cisplatin induced hearing loss. Front Cell Neurosci,...
  • Rizzi, M. y Hirose, K. (2007). Aminoglycoside ototoxicity. Current opinions in Otolaryngology and Head and Neck Surgery, 15(5), pp. 352-357.
  • Roland, P. S. y Rutka, J. A. (2004). Ototoxicity. BC Decker.
  • Romano, A. et al. (2020). Assessment and management of platinum-related ototoxicity in children treated for cancer. Cancers (Basel), 12(5),...
  • Rybak, L. P. (1993). Ototoxicity of loop diuretics. Otolaryngol Clin North Am, 26, pp. 829-844.
  • Salt, A. N. y Plontke, S. K. (2005). Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today, 10, pp. 1299-1306.
  • Sekulic-Jablanovic, M. et al. (2019). Combination of antioxidants and NFAT (nuclear factor of activated T cells) inhibitor protects auditory...
  • Sha, S. H. et al. (2006). Aspirin to prevent gentamicin-induced hearing loss. N Engl J Med, 354, pp. 1856-1857.
  • Trendowski, M. R. et al. (2019). Genetic and modifiable risk factors contributing to cisplatin-induced toxicities. Clin Cancer Res, 25(4),...
  • Truong, M. T. et al. (2007). Recovery from cisplatin-induced ototoxicity: A case report and review. Int J Pediatr Otorhinolaryngol, 71, pp....
  • van As, J. W. et al. (2019). Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. Cochrane Database...
  • Villani, V. et al. (2016). Vitamin E neuroprotection against cisplatin ototoxicity: preliminary results from a randomized, placebo-controlled...
  • Vital, I. et al. (2015). Distortion-product otoacoustic emissions testing in neonates treated with an aminoglycoside in a neonatal intensive...
  • Waissbluth, S. (2020). Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: What do we know so far?...
  • Watanabe, K. et al. (2003). Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated...
  • Weiss, A. et al. (2018). Audiological monitoring in Swiss childhood cancer patients. Pediatr Blood Cancer, 65, p. e26877.
  • Yao, L. et al. (2020). Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin....
  • Yorgason, J. G. et al. (2006). Understanding drug ototoxicity: Molecular insights for prevention and clinical management. Expert Opinion on...
  • Yu, X. et al. (2018). Paeoniflorin reduces neomycin-induced ototoxicity in hair cells by suppression of reactive oxygen species generation...
  • Zada, S. L. et al. (2020). Chemical modifications reduce auditory cell damage induced by aminoglycoside antibiotics. J Am Chem Soc, 12(6),...